[10] [11] Based on data from retatrutide clinical trials (NEJM, 2023) and experience with similar approved agents, patients may experience: Redness, swelling, or itching at the injection site, which typically resolves within a few hours to days Bruising or mild pain immediately following injection Nodules or localised reactions beneath the skin, which may occur with repeated injections at the same site These reactions are generally mild and self-limiting
Through an online visit, discuss weight loss ambitions and treatment history before receiving a personalized plan
Hendershot CS, Bremmer MP, Paladino MB, Kostantinis G, Gilmore TA, Sullivan NR, et al
Both peptides are part of the growth hormone-releasing hormone (GHRH) family and are acknowledged for their capacity to affect the patterns linked with GH release